These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 19940499)

  • 1. Safety of growth hormone treatment in children with juvenile idiopathic arthritis.
    Simon D
    Horm Res; 2009 Nov; 72 Suppl 1():65-8. PubMed ID: 19940499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of growth hormone treatment in juvenile idiopathic arthritis: bone and body composition.
    Bechtold S; Dalla Pozza R; Schwarz HP; Simon D
    Horm Res; 2009 Nov; 72 Suppl 1():60-4. PubMed ID: 19940498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of growth hormone treatment on growth in children with juvenile idiopathic arthritis.
    Simon D; Bechtold S
    Horm Res; 2009 Nov; 72 Suppl 1():55-9. PubMed ID: 19940497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early recombinant human growth hormone treatment in glucocorticoid-treated children with juvenile idiopathic arthritis: a 3-year randomized study.
    Simon D; Prieur AM; Quartier P; Charles Ruiz J; Czernichow P
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2567-73. PubMed ID: 17488793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of growth retardation in juvenile idiopathic arthritis.
    Simon D
    Horm Res; 2007; 68 Suppl 5():122-5. PubMed ID: 18174727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone improves height in patients with juvenile idiopathic arthritis: 4-year data of a controlled study.
    Bechtold S; Ripperger P; Häfner R; Said E; Schwarz HP
    J Pediatr; 2003 Oct; 143(4):512-9. PubMed ID: 14571231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear growth in children suffering from juvenile idiopathic arthritis requiring steroid therapy: natural history and effects of growth hormone treatment on linear growth.
    Simon D; Lucidarme N; Prieur AM; Ruiz JC; Czernichow P
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1483-6. PubMed ID: 11837503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mass development and bone metabolism in juvenile idiopathic arthritis: treatment with growth hormone for 4 years.
    Bechtold S; Ripperger P; Bonfig W; Schmidt H; Bitterling H; Häfner R; Schwarz HP
    J Rheumatol; 2004 Jul; 31(7):1407-12. PubMed ID: 15229964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of growth failure in juvenile chronic arthritis.
    Simon D; Lucidarme N; Prieur AM; Ruiz JC; Czernichow P
    Horm Res; 2002; 58 Suppl 1():28-32. PubMed ID: 12373011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids.
    Simon D; Fernando C; Czernichow P; Prieur AM
    J Rheumatol; 2002 Jun; 29(6):1296-300. PubMed ID: 12064849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate deterioration in glucose tolerance during high-dose growth hormone therapy in glucocorticoid-treated patients with juvenile idiopathic arthritis.
    Bismuth E; Chevenne D; Czernichow P; Simon D
    Horm Res Paediatr; 2010; 73(6):465-72. PubMed ID: 20407232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-articular corticosteroid injections to the temporomandibular joints are safe and appear to be effective therapy in children with juvenile idiopathic arthritis.
    Stoll ML; Good J; Sharpe T; Beukelman T; Young D; Waite PD; Cron RQ
    J Oral Maxillofac Surg; 2012 Aug; 70(8):1802-7. PubMed ID: 22265164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease flare after 7 year-remission of systemic type juvenile idiopathic arthritis: is growth hormone therapy a culprit or innocent bystander?
    Kim JY; Kim HS; Park SH
    Int J Rheum Dis; 2015 Mar; 18(3):377-8. PubMed ID: 24785656
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
    Horneff G; De Bock F; Foeldvari I; Girschick HJ; Michels H; Moebius D; Schmeling H;
    Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile idiopathic arthritis--current and future therapies.
    Kahn P
    Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. rhGH treatment in corticosteroid-treated patients.
    Simon D
    Horm Res; 2007; 68(1):38-45. PubMed ID: 17356290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of growth hormone therapy in childhood.
    Bowlby DA; Rapaport R
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():68-77. PubMed ID: 16456485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone therapy: emerging dilemmas.
    Laron Z
    Pediatr Endocrinol Rev; 2011 Jun; 8(4):364-73. PubMed ID: 21972776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP; Harris M; Choong CS; Ambler G; Cutfield W; Hofman P; Cowell CT; Werther G; Cotterill A; Davies PS;
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.